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Porcme leukocytes contained three homologous peptldes. PG-1, 2 and 3. that manifested potent mlcrobicidal activity against Escherrchra coli, 
Lmeriu nmocytogenes and Candida olbrcuns in vitro. The peptides (‘protegrms’) &ere composed of 16 (PG-2) or 18 amino acid residues, and, like 
tachyplesms (broad-spectrum antibiotic peptides of horseshoe crab hemocytes), they contained two intramolecular cystme disulfide bonds. 
Considerably smaller than defensins. protegrms nevertheless showed substantial homology to them. especially to the ‘corticostatic’ rabbit defensin. 
NP-3a. The relatively simple structure of protegrins should provide useful prototypes for constructmg congeners with selectively enhanced host 
defense actlvltles. 
Leukocyte: Phagocyte, Antibiotic peptide; Host-parasite relationship 
1. INTRODUCTION 
Mammalian phagocytes use antimicrobial oxidants 
[I] and an array of antimicrobial peptides and proteins 
[2,3] to kill ingested microorganisms. Unlike oxidants, 
these antimicrobial peptides and proteins show marked 
inter-species differences in structure, spectrum and po- 
tency. Among the best characterized cysteine-contain- 
ing antimicrobial peptides are ‘defensins’ [4,5] and ‘j?- 
defensins’ [6], peptides, M, -3,5004,800, the unique 
primary structural motifs of which are characterized by 
six invariant cysteines and three intramolecular cystine- 
disulfide bonds. Especially prominent in the polymor- 
phonucleated neutrophils (PMN) of humans and sev- 
eral other mammals, defensins are also produced by 
rabbit pulmonary alveolar macrophages [5] and by spe- 
cialized small intestinal epithelial (Paneth) cells in mice 
[7-91, and humans [lO,l 11. B-Defensins are found in 
bovine respiratory epithelial cells [ 121, bovine granulo- 
cytes [6] and avian leukocytes (Harwig et al., unpub- 
lished). 
We have discovered a new family of small (M, 
=2,000), cysteine-rich antimicrobial peptides (‘prote- 
grins’) in porcine leukocytes. Their novel primary struc- 
ture combines features of defensins with those of 
tachyplesins - an ancient family of antimicrobial pep- 
tides recently identified in horseshoe crab amebocytes 
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[ 131. The purification, primary structures and antibiotic 
properties of protegrins (<Latin protegere. to cover or 
protect) are described in this report. 
2. MATERIALS AND METHODS 
2.1. Leukocytes 
Fresh porcme blood was collected at an abattoir into 15 1 vessels 
that contained an anticoagulant, 5% EDTA in normal saline, pH 7.4 
(33 ml/l blood) After the blood cells had sedimented spontaneously 
for 90 min at room temperature. the leukocyte-nch supernatant was 
removed and centrifuged at 200 x g for 5-7 min. The sediments were 
pooled and suspended in 0.84% ammonium chloride to lyse the eryth- 
rocytes. The resulting leukocytes (70-758 PMN, 5-10% eosinophils, 
15-25% lymphocytes and monocytes) were washed in normal saline. 
resuspended in Ice cold 10% acetIc acid at 10” cells/ml. homogenized 
and stirred overnight at 4°C. This preparation was centrifuged at 
25,000 x g for 3 h at 4°C and Its supernatant was lyophilized and 
weighed. 
2.2 Pur(ficatiorz and antmzrcrobrul testing 
950 mg (dry weight) of lyoplnlized extract, which contained 520 mg 
of protein by BCA analysis, was stirred overmght at 4°C m 100 ml 
of 10% acetic acid. and then centrifuged at 25.000 x g for 2h. The 
supernatant was removed and passed by pressure through a 50 ml 
stirred ultrafiltration cell (Amicon. Danvers MA) that contained a 
YM-5 filter The ultrafiltrate (24 5 mg of protein by BCA) was concen- 
trated to 3 ml by vacuum centrifugation (Speed Vat Concentrator, 
Savant Instruments. Hicksville, NY), applied to a 2.5 x 117 cm col- 
umn of BioGel P-10 (Bio-Rad, Hercules, CA), eluted at 4°C with 5% 
acetic acid. and collected in 6.6 ml fractions. 
Aliquots (66 ~1) of each fraction were dried by vacuum centrifuga- 
tion, and resuspended in approximately 6.6 ~1 of 0.01% acetic acid. 5 
~1 samples of tlus concentrate were tested for antimicrobial activity 
against Escherichu colr ML-35. Listerru monoqtogenes stram EGD 
and Cundrdu ulhzcans strain 820. by previously described radial diffu- 
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slon and gel overlay techniques [14]. The underlay agars used for all 
organisms had a final pH of 6.5 and contained 9 mM sodturn phos- 
phate, 1 mM sodium citrate buffer, 1% w/v agarose and 0. 30 mg/ml 
of trypttcase soy broth powder (BBL, Cockeysville, MD). The units 
of activity in the radial diffusion assay were measured as prevtously 
described: 10 units correspond to a 1 mm diameter clear zone around 
the sample well. Active fractions were further examined by actd-urea 
(AU)-PAGE and SDS-PAGE, and the pepttdes of Interest were puri- 
fied by reverse-phase (RP)-HPLC. 
2.3. Moleculur (./1Ura(.tCYlzutlOlI 
HPLC-grade water and acetomtrile and analytical grade acetic and 
formic acids were purchased from Fisher (Pittsburgh. PA) Tri- 
fluoroacetic acid and phenylisothiocyanate were purchased from 
Pierce (Rockford. IL). Acrylamide and molecular weight standards 
were from Bethesda Research Laboratories (Bethesda, MD). 
Native and performtc acid-oxtdtzed samples were hydrolyzed m 
vacua with 6 N HCI at 110°C for 40 h. Ammo acid analysts was 
performed after phenylthiocarbamylation [15] by the Picotag tech- 
nique using a Millipore-Waters 510 binary solvent delivery system and 
a Nova-Pak C-18 column (MilhporeeWaters. Milford. MA). Ammo 
acid sequences were determined by gas-phase Edman degradation 
with a Porton Model 2090 instrument. using purtfied 500 pmol sam- 
ples of protegrms that had been reduced and alkylated with todoacettc 
actd (Sigma) in 6.0 M guamdme HCI. 0.5 M Tris-HCl, 2 mM EDTA 
(pH 8.1) and desalted by RP-HPLC on a Vydac Cl8 column. The 
mean initial yield was 55.2% (range 47 5563.8%) and the mean repet- 
itive yield was 86.4% (range 77 6692.2%) 
Fast atom bombardment (FAB)-mass spectrometric analyses were 
performed by Krtstme Swiderek and Terry D Lee at the Divtston of 
Immunology, Beckman Research Institute of the City of Hope, Du- 
arte, CA. The sample (approximately 200 pmol) was taken up m l-2 
~1 of 5% acetic actd and added to 1 yl of a mtxture of dithtothreitol: 
dtthtoerythritol (5.1) on a 1.5 x 6.0 mm stainless-steel sample cage, 
ionized with a 6 KeV Xe atom beam, and analyzed m a double fo- 
cussing JEOL HXlOOHF magnetic sector mass spectrometer. 
Chymotrypsin digests were prepared by incubating 3 nmol of each 
carboxymethylated protegrin with 0.05 pg of TLCK-treated chymo- 
trypsin (Worthington, Freehold, NJ) overnight at 37°C m 0.1 M 
ammonium bicarbonate, pH 8.5. The reaction was quenched by add- 
mg 1 vol. of glacial acetrc actd to 4 ~01s. of incubation mtwture. After 
lyophthzatton and resuspension in 0.1% trifluoroacettc acid/water, the 
peptide fragments were separated by RP-HPLC on a 0 46 x 25 cm 
Vydac Cl8 column. and subjected to ammo acid analysis. 
2.4. Other methods 
Tricine SDS-PAGE [16] and acid-urea (AU)-PAGE [17] were per- 
formed in minigel formats, using a model SE 250 vertical gel umt 
(Hoefer. San Francisco, CA) Gels were stained with a solution that 
contained 1 g of Coomassie brilliant blue R-250 (Sigma), 270 ml 
methanol, 630 ml water and 150 ml formaldehyde and destamed in 
methanol/water/formaldehyde (1:3.0.04) and then stlver-stained 1181 
The protein concentrations of column fractions and other mixtures of 
proteins mixtures was measured by the btcinchonimc actd (BCA) 
technique (Pierce Chemicals. Rockford, IL). The concentration of 
NP-1 was determined by quantitative ammo acid analysts and the 
concentration of purified protegrins and synthettc tachyplesin 1 
(Bachem. Philadelphia PA) was assessed by Azao measurements, usmg 
a millimolar extmctton coefficient of 1,280 for protegrms (which con- 
tam 1 tyrosine/molecule) and 8,250 for tachyplesm 1, which contams 
2 tyrosines and 1 tryptophan/molecule [19,20]. 
3. RESULTS 
We applied an ultrafiltration step early in our purifi- 
cation scheme to focus this analysis on molecules of 
approximately 5 kDa and below. The top portion of 
Fig. 1 illustrates the elution of the ultrafiltered leuko- 
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Fig. 1 Biogel P-10 chromatogram. A concentrated ultrafiltrate of 
porcine leukocyte peptides was prepared as described in section 2. 
eluted from the Biogel P-10 column with 5% acetic acid, and collected 
m 6 6 ml fracttons. V, stgmfies the total column volume. 
cyte extract from a BioGel P-10 column, and Fig. 2 
shows the antimicrobial activity of these PlO fractions 
against E. coli, L. monocytogenes and C. ulhicans. 
Fractions 76678. which showed strong activity 
against all of these organisms, contained a mixture of 
three peptides, the migration of which on AU-PAGE 
resembled that of the highly cationic rabbit defensins, 
NP-1. NP-2 and NP 3a,b (Fig. 3). The individual por- 
cine peptides were designated PG- 1, PG-2 and PG-3, in 
the order of their migration towards the cathode on 
AU-PAGE, with PG-1 being the fastest. Unlike the rab- 
bit defensins, which constituted > 15% of the total pro- 
tein in rabbit granulocytes and were clearly evident in 
crude extracts (lane lo), the protegrins were only faintly 
visible in crude extracts (lane 1) , and became prominent 
only after the ulrafiltration step (lane 2). Additional 
antimicrobial peptides, devoid of cysteine and therefore 
unrelated to protegrins (data not shown). were eluted 
from the column in earlier fractions and will be de- 
scribed in a future report. 
The three protegrins were readily separated by RP- 
Ftg. 2. Antibacterial acttvtty. Ahquots (66 ~1) of the 6.6 ml P-10 
fracttons shown m the previous figure were lyophilized, resuspended 
m 6.6 ~1 of 0.01% acetic acid to effect a IO-fold concentration, and 
tested against E coil ML-35~. L. motzocytogenes stram EGD and C 
ulbmms m radial diffusion assays. The pepttdes of interest for this 
report were most abundant in Fractions 76-78. 
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Fig. 3. AU-PAGE of the P-10 fractions. Lane 1. crude porcine leuko- 
cyte extract (6.0 fig protein); lane 2, YM-5 filtrate (7 pug protem), lane 
3, YM-5 retentate (18.8 pg protein): lane 4, Fraction 76 (20 ~1. 3.5 pg 
protein); lane 5, Fraction 77 (20 ~1, 6.0 pg protein): lane 6, Fraction 
78 (20 ~1, 2.6 fig protein): lane 7. Fractton 79 (20 ~1, 1.2 fig protein) 
lane 8, mtxture of equal volumes of Fracttons 76-78 (4.2pg protem). 
Lane 9, a mixture of rabbit defensms NP-1, 2. 3a. 3b, 3 and 5 (4.2 fig 
protein), The most cattomc (NP-1) and least catiomc (NP-5) rabbtt 
defensins are labeled. Lane 10. crude extract of rabbit neutrophils. The 
gel was stamed wtth Coomasste blue, 
60’ ( 
HPLC. As shown in Fig. 4, PG-1 emerged first from a 
preparative Vydac C-18 column, followed by PG-3 and 
then by PG-2, FAB-MS measurements yielded the fol- 
lowing values for monoisotopic mass: PG-1, 2,154.5; 
PG-2, 1,955.h; and PG-3 2,055.5, indicating that prote- 
grins were considerably smaller than defensins (M, 
3,500-4,500). 
l3 k.: 
Frg. 5 Antimtcrobial activity of purified porcine protegrins. Purified 
porcine protegrins PG-1. -2 and -3, rabbit defensm NP-1 and human 
defensin HNP-1 were prepared m 0 01% acetic acid at a concentration 
of 500 &ml. and seven additional ?-fold serial dtlutions were pre- 
pared in 0.01% acetic actd. 5 ,ul of each concentration was tested for 
microbictdal activity agamst E. co/i ML-35~. L. ntonoc:ltogene.s EGD 
and C rr&cu~r by radtal diffusion in thm agarose gels. Each set of 10 
units corresponds to a 1 mm diameter clear zone, devotd of viable 
bacterta, around the 3 mm sample well 
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We used a radial diffusion assay in agarose gels [14] 
to test the purified protegrins against L. monocytogenes, 
E. coli, and C. albicans (Fig. 5). Under the selected study 
conditions, PG-1 and PG-3 killed the Gram-negative 
bacterium, E. coli ML-35~ less effectively than NP- 1 but 
more effectively than HNP- 1. PG- 1 and PG-3 also killed 
the Gram-positive organism, L. moncyrogenes strain 
EGD, with considerable efficacy, approximately half 
that of the human and rabbit defensins on a weight 
basis. Both peptides, especially PG-3, also showed ex- 
cellent activity against C. a&cans. Although PG-2 was 
also active against each of these organisms, its potency 
was substantially less than that of PG-1 and PG-3, espe- 
cially at concentrations exceeding 25 ,&$ml. 
Amino acid analysis was performed on each peptide 
three times: in its native state, after its oxidation by 
performic acid, and after its reduction and alkylation by 
iodoactetic acid. As the results from these analyses were 
concordant, Table I shows only the values we obtained 
18 22 26 30 34 38 42 46 50 54 
TIME, mm 
Fig. 4. HPLC purificatton of the protegrins. Fractions 7678 from the 
PlO column were pooled and chromatographed on a 1 x 25 cm Vydac 
218TPlOlO column wtth a gradient (Buffer A, 0.1% TFA; Buffer B, 
0.1% TFA in acetomtrtle) that increased in acetomtrtle concentratton 
by l%.min-‘. The inset shows an AU-PAGE gel. stained with 
Coomassie blue, that contams the starting mixture (M). composed of 
pooled Fractions 7678. and the indtvtdual protegrin (PG) species, 
which are labeled 1. 2 and 3 on the inset 
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Table I 
Amino acid analysis of S-carboxymethylated protegrins 
July 1993 
Amino acid PC- 1 PC-2 PC-3 
Cys” 
Asx 
Glx 
Ser 
Gly 
His 
Arg 
Thr 
Ala 
Pro 
Tyr 
Val 
Met 
Ile 
Leu 
Phe 
Trp 
LYS 
mol % 
21.42 
1.01 
1.26 
0.50 
16.24 
0.00 
33.0 
0.00 
0.29 
0.13 
6.18 
9.74 
0.00 
0.20 
4 63 
5.25 
n.d. 
0.16 
nlh (nseq) 
3.9 (4) 
0.2 (0) 
0.2 (0) 
0.1 (0) 
2.9 (3) 
0.0 (0) 
5.9 (6) 
0 0 (0) 
0.1 (0) 
0.0 (0) 
1.1 (1) 
1.8 (2) 
0.0 (0) 
0.0 (0) 
0.8 (1) 
1.1 (1) 
0.0 (0) 
mol % 
25.4 
0.15 
0.27 
0.00 
11.70 
0.00 
29.2 
0.00 
0.00 
0.10 
6.2C 
8.31 
0.00 
4 94 
6 43 
7.13 
nd. 
0.16 
nlh (n,,) 
4.1 (4) 
0.0 (0) 
0.0 (0) 
0.0 (0) 
1.9 (2) 
0.0 (0) 
4.6 (5) 
0.0 (0) 
0.0 (0) 
0.0 (0) 
1.0 (1) 
1.3 (1) 
0.0 (0) 
0.8 (1) 
1.0 (1) 
1.1 (1) 
0.0 (0) 
mol % 
21.7 
0.63 
0.70 
0.00 
21.6 
0.00 
27.2 
0.00 
0.00 
0 00 
5.90 
10.38 
0.00 
0.74 
5.87 
5 16 
nd. 
0.10 
nib (n,,,) 
3.9 (4) 
0.1 (0) 
0.1 (0) 
0.0 (0) 
3.9 (4) 
0.0 (0) 
4.9 (5) 
0.0 (0) 
0.0 (0) 
0.0 (0) 
1.1 (1) 
1.9 (2) 
0 0 (0) 
0.1 (0) 
1.1 (1) 
0.9 (1) 
0.0 (0) 
Total 100.0 18.1 (18) 1000 15.8 (16) 100.0 18 0 (18) 
“Cysteine was determined as S-carboxymethylcysteine; nd. srgmfies not determined. n,8. nib, amino acid resrdues calculated from mol % determi- 
natron, assummg 18 or 16 resrdues/molecule. 
with the carboxymethylated peptides. The peptides were 
unusually rich in cysteine (21-25 mol%), arginine (27- 
33 mol%) and glycine (11.2-21.6 mol%), and contained 
tyrosine, accounting for their absorbance at 280 nm. but 
no lysine, which is prominent in tachyplesins. The re- 
maining residues were hydrophobic, and consisted of 
valine, phenylalanine, leucine, and isoleucine (PG-2 
only). 
The amino acid sequences of the protegrins were de- 
termined and are shown in Fig. 6. Chymotryptic frag- 
ments were prepared and purified from each of the PG- 
peptides. Amino acid analysis of chymotyrptic peptides 
representing residues l-5 and l-7 were consistent with 
the Arg” + Gly4 substitution found in PG-3, and frag- 
ments containing Cys13 to the carboxy-terminal residue 
confirmed the presence of an isoleucine in PG-2 and its 
truncation (data not shown). PG-1 and PG-3 contained 
18 amino acids, and were identical except for residue 4, 
which was an arginine in PG-1 and a glycine in PG-3. 
The resulting charge difference explained the slower mi- 
gration of PG-3, relative to PG-1, in AU-PAGE gels. 
PG-2 was identical to PG-1 except that it contained 
isoleucine at residue 14, instead of valine. and its car- 
boxy1 terminus had been truncated after Va116. PG-2 
was smaller than PG-3, but had the same net positive 
charge, accounting for its slightly faster migration on 
AU-PAGE. 
Although the primary amino acid sequences of the 
protegrins showed minimal homology to tachyplesins 
or p-defensins, their first 3 cysteine residues were spaced 
234 
identically to those of classical defensins, which are ex- 
emplified by HNP-1 and NP-3a in Fig. 6. In addition. 
they showed remarkable homology to the ‘corticostatic’ 
rabbit defensin. NP-3a, in that eight of the ten PG-3 
residues from Gly” to Cys13 (GLCYCRRRFC) were 
identical to residues l-10 of the rabbit defensin NP-3a 
(GICACRRRFC), and another (Leu’ of PG-3) showed 
a highly conservative substitution (Be’). Additionally, 
a tyrosine residue that corresponds to Tyr’ of PG-3 
occurs in many defensins. including human HNP-1, -2 
and -3 , rat NP-1, -2 and -4 and mouse ‘cryptdins’ 
(intestinal defensins) [4,5.7]. 
The monoisotopic molecular masses calculated from 
these sequence data are: PG-1 2,155.04, PG-2, 1.955.94 
and PC-3,2,055.96. The comparable values obtained by 
FAB-MS were: PG-1, 2,154.5; PG-2, 1,955.6; PG-3. 
2,055.5. Because FAB-MS measurements are accurate 
to within = 0.5 mass unit (0.025%) for protegrin-sized 
peptides. the experimental and calculated values are in 
excellent agreement. Nevertheless, these values do not 
exclude the possibility that the carboxy-terminal resi- 
dues of protegrins are amidated, since post-transla- 
tional carboxy-terminal amidation of protegrins would 
reduce their respective masses by 1 unit, and these 
smaller masses would also be consistent with the FAB- 
MS data. More definitive information about carboxy- 
terminal amidation of native protegrins requires addi- 
tional studies, such as solid-phase synthesis of amidated 
and non-amidated protegrins and comparison with 
their native forms. 
Volume 327, number 2 FEBSLETTERS July 1993 
Fig. 6 Ammo acid sequences of protegrins. The three protegrins have 
been aligned with human defensin HNP-1 and rabbit defensin NP-3a. 
Identical residues are boxed with double lines, conservative substttu- 
tions are boxed within a single line. Defensm residues shown m lower 
case are present in prodefensms. but are absent from the fully proc- 
essed. mature peptides. TP-1 signifies tachyplesin I. 
4. DISCUSSION 
Four principal families of cysteine-rich antimicrobial 
peptides have been recognized in animals during the 
past few years: tachyplesins [13,21], defensins [4,5], p- 
defensins [6,12] and insect defensins [22,23]. Plants also 
produce small cysteine-rich antimicrobial peptides, 
which differ from those thus far detected in animal cells 
[24,25]. 
Tachyplesins are found within the small cytoplasmic 
granules of horseshoe crab hemocytes, cells that resem- 
ble mammalian granulocytes in morphology, and are so 
abundant that approximately 10 mg of tachyplesin was 
recovered from the hemolymph of a single horseshoe 
crab [26,27] and 70 mg of tachyplesin I was obtained 
from 100 g (wet weight) of hemocytes [28]. Tachyplesins 
contain 17 or 18 amino acid residues, including four 
cysteines that form two intramolecular disulfide bonds, 
and have an amidated carboxy-terminal residue [28]. 
Although several cysteine-free antimicrobial peptides, 
including insect cecropins [29-311 and bovine leukocyte 
indolicidin [32] also have an amidated carboxy-terminal 
residue, this feature is not found in defensins [4,5], p- 
defensins [6,12] and insect defensins [22,23]. Whether 
the carboxy-terminal protegrin residue is amidated or 
not remains to be determined. 
Tachyplesins inhibited growth of various Gram-posi- 
tive and Gram-negative bacteria and of C. albicans at 
concentrations between 1.6 and 6.3 pg/ml[13] and inac- 
tivated vesicular stomatitis virus, influenza A virus and 
HIV in vitro [33.34] . They were also noted to bind to 
lipopolysaccharide (LPS) and to inhibit LPS-mediated 
activation of hemocyte factor C [13,20]. Extremely sta- 
ble, tachyplesins retained activity after boiling for 30 
min or exposure to 0.1% trifluoroacetic acid [20]. By 
two-dimensional NMR I spectroscopy [21], tachyplesin 
I had an antiparallel P-sheet configuration that was 
connected by a midsection /?-turn involving residues 
8-l 1 and stabilized by the disulfide bridges linking its 
Cys3 + Cys16 and Cy~~+Cys’~. 
The porcine protegrins described in this report resem- 
ble tachyplesins in several aspects, including: (i) their 
broad spectrum of antimicrobial activity, which encom- 
passes Gram-positive and Gram-negative bacteria and 
the fungus, C. albicans; (ii) their molecular mass of ap- 
proximately 2 kDa; (iii) the presence of four cysteine 
residues and two intramolecular cystine disulfide bonds; 
and (iv) their potent activity against certain enveloped 
viruses (Kokryakov et al., unpublished). However, the 
very different placement and spacing of the cysteine 
residues of protegrins and tachyplesins (Fig. 6) indicates 
that they belong to distinct peptide families. 
Is there a relationship between protegrins and defen- 
sins? At first sight, this seems unlikely, since protegrins 
have only 16-18 residues with four cysteines while ma- 
ture defensins, which have 29935 residues with 6 cys- 
teines, are almost twice as large. Nevertheless, this pos- 
sibility cannot be casually dismissed. The six cysteine 
residues of defensins are invariant, and constitute a crit- 
ical component of the ‘defensin motif [4,5]. Fig. 6 shows 
that the first three cysteine residues of the protegrins are 
spaced identically with the first three cysteines of classi- 
cal defensins. While this may be due to chance alone, 
it is more difficult to overlook the remarkable sim- 
ilarities between the (G4LCYCRRRFC13) deca- 
peptide region of PG-3 and corresponding residues 
(G’ICACRRRFC”) of rabbit defensin NP-3a. Eight of 
these residues are identical, while another (Leu’) is rep- 
resented by a highly conservative substitution (Ile’). Fu- 
ture studies at the mRNA and gene level should clarify 
whether this resemblance is coincidental, or signifies 
relatedness between the protegrin and defensin gene 
families. 
NP-3a, the primary sequence and antimicrobial prop- 
erties of which were first reported in 1985 [35], was later 
found to have additional properties, including ‘corti- 
costasis’, namely the ability to competitively antagonize 
ACTH-mediated steroid synthesis by adrenocytes [36- 
381. This property is believed to result from the ability 
of NP-3a to bind reversibly and with high affinity to the 
ACTH receptor of rat adrenocytes [37.38], which itself 
may derive from the mimicry of the RRR motif of 
NP-3a to the residues of ACTH responsible for binding 
to its receptor [38]. Although the in vivo significance of 
corticostasis remains conjectural, the effects of prote- 
grins on adrenal steroid production in vitro and in vivo 
warrants further study. 
Why have so many cysteine-rich antimicrobial pep- 
tides emerged in recent studies? The wide distribution 
of such peptides among animals, including arthropods, 
birds and mammals, suggests that they are not newcom- 
ers to the scene. In contrast, the elaborate lymphocyte- 
regulated immune system found in higher vertebrates is 
relatively new, at least on the time-scale of evolution. 
Since bacteria and fungi preceded them, it is reasonable 
to assume that the earliest animals derived survival ben- 
efit from chemical defense systems that supplemented 
235 
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the protective effects of their exoskeletal armor. En- 
dogenous antimicrobial peptides, cysteine-rich and oth- 
erwise, may have constituted such a phylogenetically 
primitive host defense system. The purification of a ce- 
cropin-like molecule from the intestinal tissues of pigs 
[39]. as well as the occurrence of defensin and 
tachyplesin-like molecules in phylogenetically ancient 
taxa, such as dragonflies [40] and horseshoe crabs [13], 
lends support to this notion. Delineation of such en- 
dogenous antimicrobial peptides should not only illumi- 
nate the molecular mechanisms of innate immunity, it 
may also provide time-tested molecular templates that 
can be used to develop novel therapeutic agents. 
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